
Empagliflozin + Metformin
Composition
This formulation contain combination of Empagliflozin and Metformin as active agents
Indications
his combination Formulation is indicated for the treatment of type 2 diabetes mellitus in adults
Side effects
urinary tract infections, genital yeast infections, hypoglycemia, gastrointestinal discomfort , headache, dizziness
Precautions
caution in patients with impaired renal function, as this Formulation may increase the risk of dehydration and kidney injury
Contraindications
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai